2,2,2-trifluoro-N-((2S,3S,4S,6R)-3-hydroxy-2-methyl-6-(((1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl)oxy)tetrahydro-2H-pyran-4-yl)acetamide; N-Trifluoroacetyladriamycin; NSC 283464; (8S-cis)-7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-?-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione; (1S,3S)- ?-2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)-3-glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl L-lyxo-Hexopyranoside
N-Trifluoroacetyl Doxorubicin is a fully characterized chemical compound used as a reference standard of API Doxorubicin. The standard offered is compliant with regulatory guidelines. N-Trifluoroacetyl Doxorubicin is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 26295-56-7
Related products
Doxorubicinone (Doxorubicin EP Impurity D; Epirubicin EP Impurity A)
M.F.
M.W. 414.37
CAT# AR-D02371
CAS# 24385-10-2
Doxorubicinol HCl (Mixture of Diasteromers)
M.F.
M.W. 545.54 36.46
CAT# AR-D02368
CAS# 1242592-26-2 (free base)
Doxorubicinol-13C-d3 HCl (Mixture of Diasteromers)
M.F.
M.W. 549.58 36.46
CAT# AR-D02369
CAS# 1242592-26-2 (non-labelled, free base)
